Neuralace Medical®

Neuralace Medical® company information, Employees & Contact Information

At Neuralace Medical, we are driven to accelerate the world's transition to sustainable, non-invasive chronic pain relief. What do we believe that very few others do? We fundamentally believe that overcoming chronic pain is inevitable. With our bold vision, we are challenging the conventional thinking the healthcare industry is currently laden with to implement innovations and technological advances to improve the overall quality of life of individuals by maximizing pain relief and minimizing side-effects, redefining the very concept of pain therapy which can leave patients with more side-effects than benefits. NeuraLace is not just a device developer, but also a technology company with a focus on medical innovations that can significantly restore the quality of life patients suffering from chronic pain. Our inherent interest in innovation and deep technical knowledge, along with the partnerships we are currently developing, will allow us to realize our vision and create something truly special. We are a startup medical technology company here to make a dent in the world of pain therapeutics!

Company Details

Employees
14
Founded
-
Address
16990 Goldentop Rd,
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
San Diego, California
Looking for a particular Neuralace Medical® employee's phone or email?

Neuralace Medical® Questions

News

NeuraLace Medical Expands Global Patent Portfolio as Clinical Strategy Moves Forward - PR Newswire

NeuraLace Medical Expands Global Patent Portfolio as Clinical Strategy Moves Forward PR Newswire

Current regulatory news - Today's Medical Developments

Current regulatory news Today's Medical Developments

Neuralace Medical Announces FDA Clearance of Axon Therapy for Chronic Painful Diabetic Neuropathy - PR Newswire

Neuralace Medical Announces FDA Clearance of Axon Therapy for Chronic Painful Diabetic Neuropathy PR Newswire

Neuralace Medical Announces Contract Award Totaling $1.4M Over Five Years With The Department of Veterans Affairs, Augusta, Georgia VA for Treatment of Chronic Neuropathic Pain Using Axon Therapy® - PR Newswire

Neuralace Medical Announces Contract Award Totaling $1.4M Over Five Years With The Department of Veterans Affairs, Augusta, Georgia VA for Treatment of Chronic Neuropathic Pain Using Axon Therapy® PR Newswire

Dr. Peter Staats, Chief Medical Officer at National Spine and Pain, Joins the Neuralace Medical Advisory Board as the Company Continues its Successful Seed Round Fundraising, Building Off the First Close of $3.1M While Targeting a Total Capital Raise of $ - PR Newswire

Dr. Peter Staats, Chief Medical Officer at National Spine and Pain, Joins the Neuralace Medical Advisory Board as the Company Continues its Successful Seed Round Fundraising, Building Off the First Close of $3.1M While Targeting a Total Capital Raise of $ PR Newswire

Neuralace Medical is Set to Showcase its Non-invasive Axon Therapy Using the Company's Proprietary Magnetic Peripheral Nerve Stimulation Technology (mPNS), at the North American Neuromodulation Society Conference Highlighted by Clinical Presentat - PR Newswire

Neuralace Medical is Set to Showcase its Non-invasive Axon Therapy Using the Company's Proprietary Magnetic Peripheral Nerve Stimulation Technology (mPNS), at the North American Neuromodulation Society Conference Highlighted by Clinical Presentat PR Newswire

Neuralace Medical Announces Clinical Milestones Including Presentation of the Safety and Efficacy of Axon Therapy (SEAT) Study at the American Society of Pain and Neuroscience Conference (ASPN), While Completing Enrollment in the Axon Therapy Painf - PR Newswire

Neuralace Medical Announces Clinical Milestones Including Presentation of the Safety and Efficacy of Axon Therapy (SEAT) Study at the American Society of Pain and Neuroscience Conference (ASPN), While Completing Enrollment in the Axon Therapy Painf PR Newswire

Neuralace Medical Announces First Patients Enrolled in the AT-PDN Study Evaluating Axon Therapy® for the Treatment of Painful Diabetic Neuropathy - PR Newswire

Neuralace Medical Announces First Patients Enrolled in the AT-PDN Study Evaluating Axon Therapy® for the Treatment of Painful Diabetic Neuropathy PR Newswire

NEURALACE MEDICAL ANNOUNCES THE AMERICAN MEDICAL ASSOCIATION ISSUES UNIQUE CATEGORY III CPT® CODE FOR TRANSCUTANEOUS MAGNETIC NERVE STIMULATION - PR Newswire

NEURALACE MEDICAL ANNOUNCES THE AMERICAN MEDICAL ASSOCIATION ISSUES UNIQUE CATEGORY III CPT® CODE FOR TRANSCUTANEOUS MAGNETIC NERVE STIMULATION PR Newswire

NeuraLace Medical Announces Appointment of Keith Warner as Chief Executive Officer - PR Newswire

NeuraLace Medical Announces Appointment of Keith Warner as Chief Executive Officer PR Newswire

Top Neuralace Medical® Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant